Gene: MCM10
Official Full Name: minichromosome maintenance 10 replication initiation factorprovided by HGNC
Gene Summary: The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are involved in the initiation of eukaryotic genome replication. The hexameric protein complex formed by MCM proteins is a key component of the pre-replication complex (pre-RC) and it may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. This protein can interact with MCM2 and MCM6, as well as with the origin recognition protein ORC2. It is regulated by proteolysis and phosphorylation in a cell cycle-dependent manner. Studies of a similar protein in Xenopus suggest that the chromatin binding of this protein at the onset of DNA replication is after pre-RC assembly and before origin unwinding. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01431 | MCM10 Knockout cell line(KYSE-150) | Human | MCM10 | 1:2~1:4 | Negative | Online Inquiry |
KO01432 | MCM10 Knockout cell line(KYSE-30) | Human | MCM10 | 1:2~1:4 | Negative | Online Inquiry |
MCM10 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the MCM10 gene, which is essential for the initiation of DNA replication. MCM10 functions as a critical component of the MCM2-7 complex, acting as a mediator for polymerase loading during the DNA replication process. By creating knockout models, researchers can dissect the role of MCM10 in replication fidelity, chromatin dynamics, and cellular responses to DNA damage, thus allowing for a deeper understanding of its contribution to genomic stability and cell cycle regulation.
These knockout cell lines serve a multifaceted purpose in both basic and applied research settings. They are invaluable for investigating the molecular pathways involved in tumorigenesis, as dysfunction in MCM10 has been linked to various cancers. Furthermore, these models can facilitate drug discovery efforts targeting replication-associated pathways, potentially leading to novel therapies, especially in oncology.
One of the significant advantages of MCM10 Gene Knockout Cell Lines is their specificity and robustness. Unlike conventional methods of gene manipulation, which may yield off-target effects, the precise knockout provides a clean background for studying the consequences of MCM10 depletion. This specificity is critical for obtaining reproducible experimental results, making these cell lines a preferred option for research focused on DNA replication and repair mechanisms.
Researchers and clinicians will find MCM10 Gene Knockout Cell Lines beneficial for advancing their studies in cancer biology, cell cycle dynamics, and therapeutic developments. Given the rising importance of personalized medicine, understanding the genetic underpinnings of diseases through such advanced models can lead to improved treatment strategies.
Our company brings unparalleled expertise in the development of genetically modified cell lines, ensuring that our products not only meet but exceed rigorous scientific standards. By choosing MCM10 Gene Knockout Cell Lines, users gain access to a unique tool for unraveling complex biological questions and driving innovation in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.